Replies to post #1120 on NightHawk Biosciences Inc (NHWK)

[dia76ca]

It is good to have this strong statement. I am looking forward to a short squeeze very soon!

“We are pleased with the progress we are making and look forward to reporting top-line data in both our NMIBC and NSCLC trials later this quarter,” commented Jeff Wolf, Heat’s Founder and CEO. “We are encouraged by our early data in bladder cancer that suggests we are activating a robust antigen-specific immune response and our data in lung cancer that suggest HS-110 may improve response rates for patients with ‘cold tumors’ who typically have lower response rates to checkpoint inhibitor monotherapy.”

[Rogerthat1]

Do you know when within this quarter will data be dropped? Multiple trials here and previous results encouraging imo.